Literature DB >> 21905783

Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Pingsheng Wu1, Tina V Hartert.   

Abstract

Respiratory syncytial virus (RSV) infects all children early in life, is the most common cause of infant lower respiratory tract infections, and causes disease exacerbations in children with asthma. Episodes of lower respiratory tract infection in early life are associated with asthma development. Whether RSV infection early in life directly causes asthma or simply identifies infants who are genetically predisposed to develop subsequent wheezing is debatable. Recent studies suggest that these two explanations are not mutually exclusive, and are likely both important in asthma development. An open-label study of RSV immunoprophylaxis administered to preterm infants reduced recurrent wheezing by 50%. Clinical trials of infant RSV prevention, delay or severity reduction on the outcome of childhood asthma would confirm the causal relationship between RSV infection and asthma, and offer a primary prevention strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905783      PMCID: PMC3215509          DOI: 10.1586/eri.11.92

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  128 in total

1.  Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments.

Authors:  Waltraud Eder; Walt Klimecki; Lizhi Yu; Erika von Mutius; Josef Riedler; Charlotte Braun-Fahrländer; Dennis Nowak; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent.

Authors:  K K Tekkanat; H F Maassab; D S Cho; J J Lai; A John; A Berlin; M H Kaplan; N W Lukacs
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

3.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

4.  Altered respiratory tissue mechanics in asymptomatic wheezy infants.

Authors:  G L Hall; Z Hantos; P D Sly
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

5.  Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.

Authors:  R S Peebles; J R Sheller; R D Collins; A K Jarzecka; D B Mitchell; R A Parker; B S Graham
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

6.  The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Authors:  John S Tregoning; Yuko Yamaguchi; James Harker; Belinda Wang; Peter J M Openshaw
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

7.  Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester.

Authors:  A A Baschat; J Towbin; N E Bowles; C R Harman; C P Weiner
Journal:  J Matern Fetal Neonatal Med       Date:  2003-06

8.  Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs.

Authors:  Chengping Hu; Katrin Wedde-Beer; Alexander Auais; Maria M Rodriguez; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

Review 9.  Respiratory syncytial virus and pulmonary surfactant.

Authors:  Matthias Griese
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

10.  Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection.

Authors:  Beena Puthothu; Marcus Krueger; Johannes Forster; Jessica Heinze; Markus Weckmann; Andrea Heinzmann
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129

View more
  84 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

2.  Early-life wheezing and respiratory syncytial virus prevention.

Authors:  Robert F Lemanske
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

3.  Bronchiolitis: Comparative Study between Respiratory Synctial Virus (RSV) and Non RSV Aetiology.

Authors:  Anirban Mandal; Amitabh Singh; Puneet Kaur Sahi; Bhavika Rishi
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 4.  Ongoing developments in RSV prophylaxis: a clinician's analysis.

Authors:  Fariba Rezaee; Debra T Linfield; Terri J Harford; Giovanni Piedimonte
Journal:  Curr Opin Virol       Date:  2017-05-10       Impact factor: 7.090

5.  Gestational age-specific associations between infantile acute bronchiolitis and asthma after age five.

Authors:  Matthew J Strickland; Caitlin A Marsh; Lyndsey A Darrow
Journal:  Paediatr Perinat Epidemiol       Date:  2014-09-25       Impact factor: 3.980

6.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

7.  Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Authors:  S Boyoglu-Barnum; S O Todd; J Meng; T R Barnum; T Chirkova; L M Haynes; S J Jadhao; R A Tripp; A G Oomens; M L Moore; L J Anderson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 8.  Is asthma an infectious disease? New evidence.

Authors:  T Prescott Atkinson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

9.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

Review 10.  Asthma across the ages: knowledge gaps in childhood asthma.

Authors:  Stanley J Szefler; James F Chmiel; Anne M Fitzpatrick; George Giacoia; Thomas P Green; Daniel J Jackson; Heber C Nielsen; Wanda Phipatanakul; Hengameh H Raissy
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.